S

Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399

Watchlist Manager
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Watchlist
Price: 11.06 CNY -0.09%
Market Cap: 13.8B CNY
Have any thoughts about
Shenzhen Hepalink Pharmaceutical Group Co Ltd?
Write Note

Shenzhen Hepalink Pharmaceutical Group Co Ltd
Cash Paid for Dividends

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shenzhen Hepalink Pharmaceutical Group Co Ltd
Cash Paid for Dividends Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Cash Paid for Dividends Analysis
Latest Figures & CAGR of Competitors

Company Cash Paid for Dividends CAGR 3Y CAGR 5Y CAGR 10Y
S
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Cash Paid for Dividends
-ÂĄ370.9m
CAGR 3-Years
7%
CAGR 5-Years
-8%
CAGR 10-Years
-17%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash Paid for Dividends
-ÂĄ652.1m
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash Paid for Dividends
-ÂĄ2.2B
CAGR 3-Years
-57%
CAGR 5-Years
-41%
CAGR 10-Years
-28%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash Paid for Dividends
-ÂĄ40.4m
CAGR 3-Years
66%
CAGR 5-Years
47%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash Paid for Dividends
-ÂĄ3.7B
CAGR 3-Years
9%
CAGR 5-Years
-10%
CAGR 10-Years
-22%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cash Paid for Dividends
-ÂĄ18.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Shenzhen Hepalink Pharmaceutical Group Co Ltd's Cash Paid for Dividends?
Cash Paid for Dividends
-370.9m CNY

Based on the financial report for Jun 30, 2024, Shenzhen Hepalink Pharmaceutical Group Co Ltd's Cash Paid for Dividends amounts to -370.9m CNY.

What is Shenzhen Hepalink Pharmaceutical Group Co Ltd's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 10Y
-17%

Over the last year, the Cash Paid for Dividends growth was -47%. The average annual Cash Paid for Dividends growth rates for Shenzhen Hepalink Pharmaceutical Group Co Ltd have been 7% over the past three years , -8% over the past five years , and -17% over the past ten years .

Back to Top